摘要
目的探讨无创正压通气(NIPPV)在肺部感染合并急性Ⅰ型呼吸衰竭中应用的临床疗效。方法将42例肺部感染合并急性Ⅰ型呼吸衰竭患者随机分为治疗组和对照组。治疗组在对照组常规药物治疗基础上,经面罩行无创通气,观察两组患者的症状、体征、血气改变及最后转归。结果与对照组相比,治疗组患者病情和血气分析指标恢复较快,临床效果满意。治疗组转有创通气者4例,对照组最终转有创通气者10例,两者比较差异较明显。结论无创通气治疗肺部感染合并Ⅰ型呼吸衰竭,是安全、有效、可行的,对于肺部感染合并Ⅰ型呼吸衰竭患者早期应用无创正压通气可降低转有创通气的概率,从而减少并发症的发生,挽救患者的生命,提高生活质量,值得推广应用。
Objective To evaluate the effect of noninvasive positive-pressure ventilation（NIPPV） in the treatment of pulmonary infection with type I respiratory failure.Methods 42 cases of such patients were randomly divided to treatment group and control group.In the treatment group,on the basis conventional drug treatment of the control group,non-invasive ventilation via face mask were performed.To observe the symptoms,signs,blood gas changes and the final outcome of two groups.Results Noninvasive ventilation in the treatment of pulmonary infection associated with l-type respiratory failure is safe,effective and feasible.Conclusion For pulmonary infection combined l-type respiratory failure in patients with early application of noninvasive positive pressure ventilation can reduce the probability of invasive ventilation,thereby reducing the incidence of complications and save the lives of patients and improve quality of life.It should be widely applied in clinic.
出处
《黑龙江医学》
2012年第6期412-414,共3页
Heilongjiang Medical Journal
关键词
无创正压通气
急性Ⅰ型呼吸衰竭
肺部感染
Noninvasive positive-pressure ventilation
Type Ⅰ respiratory failure
Pulmonary infection
